Author = Nasser Mousa
| Number of Articles: 12 | ||||
| 1 | Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases | |||
| Volume 7.2, Issue 2, April 2023, Page 1-8 | ||||
| Nasser Mousa; Ahmed EL-Eraky; Mona Arafa; Hatem Elalfy; Raghda Farag; Ahmed Abdel-Razik; Talaal Amer | ||||
| 2 | Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study | |||
| Volume 5.3, Issue 3, September 2021, Page 1-7 | ||||
| Ahmed Yassen; Nasser Mousa; Ahmed Abdel-Razik; Rasha Mahmoud; Alaa Habib; Eman Mousa; Niveen El-Wakeel; Aya Fathy; Sally Abdallah Mostafa; Narmin Saied; Muhammad Diasty; Aya Mousa; Essam Elmahdi | ||||
| 3 | Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study | |||
| Volume 5.1, Issue 1, November 2020, Page 41-45 | ||||
| Sahar Zakaria; Nasser mousa; Ahmed Abdel-Razik; Mahmoud El-Bendary; Mahmoud Awad; Ahmed Taha; Eman Mousa; Ahmed Yassen; Kamal Salama; Aya Ahmed Fathy; Muhammad Diasty | ||||
| 4 | Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy | |||
| Volume 4.2, Issue 2, March 2020, Page 69-73 | ||||
| Elhammady Dina; Mousa Nasser; Eissa Sarah; Awad Mahmoud; Mohamed Islam; Eldars Waleed; Diasty Muhammad | ||||
| 5 | Non Hodgkin lymphoma of the cecum; case report | |||
| Volume 4.1, Issue 1, November 2019, Page 1-4 | ||||
| Mohammed Abdelaziz; Ahmed El Shabrawi; Nasser Mousa | ||||
| 6 | Portal Hypertension, an Overview | |||
| Volume 4.1, Issue 1, November 2019, Page 15-21 | ||||
| Mohammad Elmoghazy; Ahmed El Shabrawi; Nasser Mousa | ||||
| 7 | Nutritional status in cirrhosis; pathogenesis and management | |||
| Volume 3.2, Issue 2, April 2019, Page 41-47 | ||||
| Mousa Nasser; Mokhtar Abdelrahman; Abbas Neven; awad Mahmoud; Ibrahim Adel | ||||
| 8 | Hepatitis B Virus: Update in Management | |||
| Volume 3.2, Issue 2, April 2019, Page 49-56 | ||||
| Abdelhamed Mohamed; El Badawy Reda; Abdelaziz Mohamed; Mousa Nasser | ||||
| 9 | The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B | |||
| Volume 3.2, Issue 2, April 2019, Page 57-64 | ||||
| Mousa Nasser; Abdel-Razik Ahmed; Talat qattan Ilham; sheta Tarek; Rizk Hassan; Deiab Ahmed; Elshazly Atef; Elshinawy Farha | ||||
| 10 | B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection | |||
| Volume 3.1, Issue 1, November 2018, Page 27-35 | ||||
| Mousa Nasser; Alfar Marwa; Abd El- Maksoud Mohamed | ||||
| 11 | Hepatorenal Syndrome: Update on pathogenesis and management | |||
| Volume 2.2, Issue 2, March 2018, Page 7-14 | ||||
| Mousa Nasser; Elgamal Hoda; El- Eraky Ahmed; Soliman Reham; Awad Mahmoud | ||||
| 12 | Recent trends in chronic hepatitis C virus treatment | |||
| Volume 2.2, Issue 2, March 2018, Page 1-6 | ||||
| abed Sally; Mousa Nasser; Abdel-Aziz Mahmoud; Farag Raghda; Hasson Amany; Soliman Reham | ||||
| | ||||
View on SCiNiTO